STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more

RegulatoryapprovedEnbrelPositive

AI Analysis

Summary

A U.S. judge blocked a Colorado state panel from imposing a price cap on Amgen's blockbuster drug Enbrel, representing a court win for Amgen in a pricing dispute.

Outcome Details

U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel

Importance:6/10

Sentiment:

0.70

pricinglitigationregulatoryEnbrelcourt decision

Related Companies

$AMGN

Read the original article

Published by STAT News on July 2, 2026 1:25 PM

Read Original